Enzon Pharmaceuticals, Inc. to Present Preclinical Data From PEG-SN38 and PEGylation Technology Studies at American Association for Cancer Research Meeting

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced today that four posters containing preclinical data will be presented at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) to be held from April 14 – 18, 2007 in Los Angeles, CA.

MORE ON THIS TOPIC